Declaration of Final Dividend of Rs 4/- per equity share of Rs. 10 each for the financial year ended March 31, 2026.
DRAGARWQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr Agarwal's Eye Hospital reported FY2026 results with Revenue from Operations growing 18.6% to ₹470.87 Cr from ₹397.15 Cr in FY2025. Net Profit after Tax surged 28.3% to ₹70.10 Cr from ₹54.65 Cr. Basic EPS stands at ₹147.02 vs ₹116.28 prior year. The Board recommended a final dividend of Rs 4 per share (40%), which combined with the interim dividend of Rs 3 already paid earlier in the year makes total dividend of Rs 7 per share (70%). The company also completed a ₹70 Cr preferential issue to its holding company during the year. S.R. Batliboi & Associates LLP issued an unmodified opinion on the audited results.
Strong financial performance with PAT growth exceeding 25% and robust dividend payout signals healthy earnings and cash generation. The stock should be viewed positively given consistent profitability and shareholder returns.